Actively Recruiting
Clinical Efficacy Trial of Burdock Root Extract in Patients With Asymptomatic Hyperuricaemia
Led by OMNIFARMA LLC · Updated on 2025-07-30
100
Participants Needed
1
Research Sites
28 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Multicentre, double-blind, randomized, placebo-controlled trial of the clinical efficacy of burdock root extract in patients with asymptomatic hyperuricemia, with the primary objective to assess the efficacy of the use of burdock root extract in patients with asymptomatic hyperuricaemia versus placebo
CONDITIONS
Official Title
Clinical Efficacy Trial of Burdock Root Extract in Patients With Asymptomatic Hyperuricaemia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Hyperuricaemia confirmed by laboratory: uric acid 360 to 540 µmol/L in women and 420 to 540 µmol/L in men
- Age between 35 and 65 years at baseline
- Examined by a specialist with no signs of gout or other hyperuricaemia symptoms
- Not taking any other nutritional supplements
- Women of reproductive age with negative pregnancy test at baseline and trial end
- Stable use or no use of diuretics without recent changes
- Not participating in other clinical trials
- Provided signed informed consent for study participation
You will not qualify if you...
- Age younger than 35 or older than 65 years
- Fever above 36.8 °C
- Pregnancy or breastfeeding
- Signs of gout or other hyperuricaemia complications with recent use of antigout drugs
- Mental disorders or use of antipsychotics or antidepressants
- Lack of informed consent
- Doubts about motivation to comply with the trial
- Presence of serious or acute diseases affecting study results
- Alcohol abuse or drug addiction
- Changes in diuretic use within one month before or during the trial
- Participation in other clinical trials
- Use of any nutritional supplements
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
State Institution "National Research Centre "Academician M. D. Strazhesko Institute of Cardiology
Kyiv, Ukraine, 03151
Actively Recruiting
Research Team
O
Oleg V Kurchenko, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here